1.
Cost-effectiveness analysis of preloaded versus non-preloaded Descemet membrane endothelial keratoplasty for the treatment of Fuchs endothelial corneal dystrophy in an academic centre.
Böhm Myriam, Leon Pia, Wylęgała Adam, Ong Tone Stephan, Condron Tracy, Jurkunas Ula
Br J OphthalmolFeb 202111 citationsCohort Study
This study found preloaded DMEK for Fuchs dystrophy was more cost-effective than non-preloaded, offering slightly better utility at lower cost, suggesting clinical and economic benefits.